CN87105215A - 纯化的胎儿胸腺嘧啶脱氧核苷激酶 - Google Patents

纯化的胎儿胸腺嘧啶脱氧核苷激酶 Download PDF

Info

Publication number
CN87105215A
CN87105215A CN198787105215A CN87105215A CN87105215A CN 87105215 A CN87105215 A CN 87105215A CN 198787105215 A CN198787105215 A CN 198787105215A CN 87105215 A CN87105215 A CN 87105215A CN 87105215 A CN87105215 A CN 87105215A
Authority
CN
China
Prior art keywords
thymidine
purified
carrier
eluted
thymidine kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN198787105215A
Other languages
English (en)
Chinese (zh)
Inventor
彼里·尼科拉斯·约安
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Debat Fr Ste
Original Assignee
Laboratoires Debat Fr Ste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Debat Fr Ste filed Critical Laboratoires Debat Fr Ste
Publication of CN87105215A publication Critical patent/CN87105215A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CN198787105215A 1986-07-31 1987-07-30 纯化的胎儿胸腺嘧啶脱氧核苷激酶 Pending CN87105215A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8611101A FR2602242B1 (fr) 1986-07-31 1986-07-31 Thymidine kinase de type foetal purifiee
FR8611101 1986-07-31

Publications (1)

Publication Number Publication Date
CN87105215A true CN87105215A (zh) 1988-02-24

Family

ID=9337917

Family Applications (1)

Application Number Title Priority Date Filing Date
CN198787105215A Pending CN87105215A (zh) 1986-07-31 1987-07-30 纯化的胎儿胸腺嘧啶脱氧核苷激酶

Country Status (14)

Country Link
EP (1) EP0255431B1 (cg-RX-API-DMAC10.html)
JP (1) JPS6359886A (cg-RX-API-DMAC10.html)
CN (1) CN87105215A (cg-RX-API-DMAC10.html)
AT (1) ATE68821T1 (cg-RX-API-DMAC10.html)
AU (1) AU594486B2 (cg-RX-API-DMAC10.html)
DE (1) DE3774025D1 (cg-RX-API-DMAC10.html)
DK (1) DK387387A (cg-RX-API-DMAC10.html)
ES (1) ES2038681T3 (cg-RX-API-DMAC10.html)
FR (1) FR2602242B1 (cg-RX-API-DMAC10.html)
GR (1) GR3003416T3 (cg-RX-API-DMAC10.html)
IE (1) IE61237B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ221246A (cg-RX-API-DMAC10.html)
PT (1) PT85406B (cg-RX-API-DMAC10.html)
ZA (1) ZA875378B (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE239784T1 (de) * 1993-08-06 2003-05-15 Univ Brigham Young Monoklonale antikörper gegen isozyme der thymidinkinase
SE9401380D0 (sv) * 1994-04-22 1994-04-22 Sven Skog Ny celltillväxt-relaterad peptid och användning därav
CN1301821A (zh) * 1999-12-27 2001-07-04 上海博德基因开发有限公司 一种新的多肽——胸腺嘧啶核苷酸激酶11和编码这种多肽的多核苷酸
US7311906B2 (en) 2004-04-30 2007-12-25 Brigham Young University Anti-viral activity of an anti-thymidine kinase monoclonal antibody
US8551486B2 (en) 2004-05-21 2013-10-08 Savoy Pharmaceuticals, Inc. Monoclonal antibodies to human thymidine kinase to treat cancer
US7837998B2 (en) 2004-05-21 2010-11-23 Nathaniel Lallatin Anti-cancer activity of an anti-thymidine kinase monoclonal antibody
WO2011082345A2 (en) 2009-12-30 2011-07-07 Brigham Young University Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2028588A1 (de) * 1970-06-10 1971-12-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur Gewinnung von Thymidin-Kinase

Also Published As

Publication number Publication date
AU594486B2 (en) 1990-03-08
EP0255431B1 (fr) 1991-10-23
FR2602242A1 (fr) 1988-02-05
PT85406A (fr) 1987-08-01
JPS6359886A (ja) 1988-03-15
ATE68821T1 (de) 1991-11-15
ES2038681T3 (es) 1993-08-01
JPH0438392B2 (cg-RX-API-DMAC10.html) 1992-06-24
DE3774025D1 (de) 1991-11-28
DK387387D0 (da) 1987-07-24
GR3003416T3 (en) 1993-02-17
DK387387A (da) 1988-02-01
ZA875378B (en) 1988-01-29
NZ221246A (en) 1991-05-28
IE61237B1 (en) 1994-10-19
EP0255431A1 (fr) 1988-02-03
PT85406B (pt) 1990-04-30
IE872064L (en) 1988-01-31
AU7607587A (en) 1988-02-04
FR2602242B1 (fr) 1989-05-26

Similar Documents

Publication Publication Date Title
FI86436C (fi) Foerfarande foer framstaellning av faktor viii:c och daertill hoerande vektorer och saollningsmedel.
Gerlich et al. Specificity and localization of the hepatitis B virus-associated protein kinase
Oren et al. Differential affinities of simian virus 40 large tumor antigen for DNA.
US6001580A (en) Method for assaying ERK2 map kinase
Krohne et al. Immunological localization of a major karyoskeletal protein in nucleoli of oocytes and somatic cells of Xenopus laevis.
JP3093116B2 (ja) 核酸検出方法
JP2001505063A (ja) ＩκＢキナーゼ類
Jeng et al. Adenovirus type 2 coded single-stranded DNA binding protein: in vivo phosphorylation and modification
AU599310B2 (en) A preparation for the treatment of hemophilia a inhibitor patients and a process for producing such a preparation
AU7559694A (en) Monoclonal antibodies to thymidine kinase isozymes
AU2140392A (en) Purification and cloning of p62
Chevesich et al. Characterization of mammalian translation initiation factor 5 (eIF-5). Demonstration that eIF-5 is a phosphoprotein and is present in cells as a single molecular form of apparent M (r) 58,000.
JP4848358B2 (ja) 非メチル化ＣｐＧモチーフを含むＤＮＡに特異的に結合するタンパク質を用いて原核生物ＤＮＡの濃縮または分離のうち少なくともいずれか一方を行う方法
Luche et al. Expression of rat CTP: phosphocholine cytidylyltransferase in insect cells using a baculovirus vector
Symington et al. Biosynthesis of adenovirus type 2 i-leader protein
NZ221246A (en) Purification of thymidine kinase and antibodies
AU627764B2 (en) Gap gene sequences and diagnostic uses thereof
Piñol-Roma et al. Purification and characterization of proteins of heterogeneous nuclear ribonucleoprotein complexes by affinity chromatography
Nakao et al. A novel antibody wich precipitates 7.5 S RNA is isolated from a patient with autoimmune disease
IE67563B1 (en) A process for the isolation of basement membrane proteins from human and animal tissues
JPS62259596A (ja) ハイブリツドタンパク質の精製方法
Gelsthorpe et al. Extraction of DNA using monoclonal anti-DNA and magnetic beads
JP3122963B2 (ja) モノクローナル抗体
Matunis et al. Isolation and characterization of RNA-binding proteins from Drosophila melanogaster
Marks et al. Conservation of the DNA binding domain and other properties between porcine and rat glucocorticoid receptors

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: French saisong - Savannah

Agency after: Shanghai Patent Law Office Zhang Mingyu

Agent after: Zhang Mingyu

Applicant after: Jouan Pierre

Address before: Paris France

Agency before: Patent Agency of China Council For The Promotion Of International Trade

Agent before: Gu Baidai

Applicant before: Laboratoires Debat Societe (FR)

Agent before: Li Ying

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: LABORATOIRES DEBAT SOCIETE (FR) 60, RUE DE MONCEAU 75008 PARIS-FRANCE TO:PIERRE JOUAN; AGENCY; FROM: CHINA INTERNATIONAL TRADE PROMOTING COMMITTEE PATENT AGENCY DEPARTMENT TO: SHANGHAI PATENT OFFICE; AGENT; FROM: GU BODI; LI YING TO: ZHANG MINGYU

C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication